Sunday, June 3, 2018
- 5:18pm-5:30pm
-
Assessment and Validation of Potential Predictors of Non-Adherence in Contemporary Kidney Transplant Recipients
Concurrent Session: Kidney Psychosocial - 1 • Room 210
- 5:18pm-5:30pm
-
Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial
- 5:18pm-5:30pm
-
Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial
Concurrent Session: Kidney Transplant Goes Viral • Room 606/607
- 5:18pm-5:30pm
-
Development and Validation of a Socioeconomic Kidney Transplant Derailers Index (KTDI)
- 5:18pm-5:30pm
-
Graft Dendritic Cell p40 Homodimers Activate Donor-Reactive Endogenous Memory CD8 T Cells within Higher Risk Allografts
Concurrent Session: Acute Rejection • Room 6A
- 5:18pm-5:30pm
-
Metabolic Therapy as a Platform for CTLA4Ig Costimulation Blockade in Preventing Allograft Rejection
Concurrent Session: Novel Therapeutics • Room 602/603/604
- 5:18pm-5:30pm
-
T Cell-Mediated Rejection Poses Greater Risk to Graft Survival Than Antibody-Mediated Rejection in Heart Transplants
- 5:18pm-5:30pm
-
Treatment Outcomes of Recurrent Primary Focal Segmental Glomerulosclerosis (FSGS) after Kidney Transplantation
Concurrent Session: Kidney Complications: Disease Recurrence • Room Hall 4B
- «Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 57
- Next Page»